Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
Clinical trial NCT05896007 · UNKNOWN
Trial details
- NCT number
- NCT05896007
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2025-12-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.